Pediatric chagas disease in Europe: 45 cases from Spain and Switzerland

Pediatric Infectious Disease Journal

Volumn 33, Issue 5, 2014, Pages 458-462

  Rodriguez Guerineau, Luciana ^a,b   Posfay Barbe, Klara M ^a   Monsonis Cabedo, Manuel ^c   Juncosa Morros, Teresa ^c   Diana, Alessandro ^a   Wyler Lazarevic, Claire Anne ^a   De Tejada, Begoña Martinez ^d   Chappuis, François ^e   Fumadó Pérez, Victoria ^b   Jackson, Yves ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Department of Gynecology and Obstetrics ^*  (Spain)

^e Division of International and Humanitarian Medicine Department of Community Medicine Primary Care and Emergency Medicine   (Spain)

Author keywords

Chagas disease; children; Europe; migration; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX; ANTIPROTOZOAL AGENT;

ADULT; ANEMIA; ANOREXIA; ARGENTINA; ARTICLE; BOLIVIA; CHAGAS DISEASE; CHILD; CLINICAL ARTICLE; CONGENITAL INFECTION; FEMALE; FOLLOW UP; HUMAN; INFECTION; MALE; MEDICAL RECORD REVIEW; MEGAESOPHAGUS; NEWBORN; NICARAGUA; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; RASH; SEROLOGY; SPAIN; SWITZERLAND; TREATMENT DURATION; WEIGHT GAIN; ADOLESCENT; COMMUNICABLE DISEASES, EMERGING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGY; EUROPE; INFANT; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTIPROTOZOAL AGENTS; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EUROPE; HUMANS; INFANT; MALE; SPAIN; SWITZERLAND; TREATMENT OUTCOME;

EID: 84899472029     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000139     Document Type: Article

References (32)

1. World Health Organization. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases. Geneva: WHO; 2013.
2. World Health Organization. Control of Chagas Disease. Brasilia (Brazil): WHO; 2002.
3. Alonso-Vega C, Billot C, Torrico F. Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009. PLoS Negl Trop Dis. 2013;7:e2304.
4. Moscatelli G, García Bournissen F, Freilij H, et al. Impact of migration on the occurrence of new cases of Chagas disease in Buenos Aires city, Argentina. J Infect Dev Ctries. 2013;7:635-637.
5. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14-21.
6. Basile L, Jansa JM, Carlier Y, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16:1-10.
7. World Health Organization. Chagas Disease in Europe. Geneva: WHO; 2010.
8. Castro E. Chagas' disease: lessons from routine donation testing. Transfus Med. 2009;19:16-23.
9. Jackson Y, Myers C, Diana A, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis. 2009;15:601-603.
10. Muñoz J, Portús M, Corachan M, et al. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg. 2007;101:1161-1162.
11. World Health Organization. Control and Prevention of Chagas Disease in Europe. Report of a WHO Informal Consultation (jointly organized by WHO headquarters and the WHO Regional Office for Europe) Geneva, Switzerland; December 17-18XXX, 2009. Geneva: WHO, 2009.
12. Organizacion Panamericana de la Salud. Estimacion cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: PAHO; 2006
13. Zulantay I, Apt W, Ramos D, et al. The epidemiological relevance of family study in Chagas disease. PLoS Negl Trop Dis. 2013;7:e1959.
14. Spanish National Institute of Statistics. Estadística de Migraciones. 2013. Available at: http://www.ine.es. Accessed March 31, 2013.
15. Muñoz J, Coll O, Juncosa T, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48:1736-1740.
16. Jackson Y, Gétaz L, Wolff H, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis. 2010;4:e592.
17. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298:2171-2181.
18. Spanish National Institute of Statistics. Adopciones internacionales por países y periodo. 2012. Available at: http://www.ine.es/jaxi/tabla. dotype=pcaxis&path=/t25/a072/a02/l0/&file=c70004.px. Accessed November 11, 2012.
19. Swiss Federal Bureau of Statistics. Population movements: adoptions. 2010. Available at: http://www.pxweb.bfs.admin.ch/. Accessed September 5, 2012.
20. Lee BY, Bacon KM, Bottazzi ME, et al. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13:342-348.
21. Sicuri E, Muñoz J, Pinazo MJ, et al. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop. 2011;118:110-117.
22. Jackson Y, Alirol E, Getaz L, et al. Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis. 2010;51:e69-e75.
23. Pinazo MJ, Guerrero L, Posada E, et al. Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease. Antimicrob Agents Chemother. 2013;57:390-395.
24. Sosa-Estani S, Segura EL. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr Opin Infect Dis. 2006;19:583-587.
25. Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop. 2010;115:55-68.
26. Yun O, Lima MA, Ellman T, et al. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl Trop Dis. 2009;3:e488.
27. Escribà JM, Ponce E, Romero Ade D, et al. Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras. Mem Inst Oswaldo Cruz. 2009;104:986-991.
28. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388-1402.
29. Jackson Y, Chatelain E, Mauris A, et al. Serological and parasitological response in chronic Chagas patients 3 years after nifurtimox treatment. BMC Infect Dis. 2013;13:85.
30. Viotti R, Vigliano C, Alvarez MG, et al. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis. 2011;5:e1314.
31. Jackson Y, Castillo S, Hammond P, et al. Metabolic, mental health, behavioural and socioeconomic characteristics of migrants with Chagas disease in a non-endemic country. Trop Med Int Health. 2012;17:595-603.
32. Almeida EA, Ramos Júnior AN, Correia D, et al. Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010). Rev Soc Bras Med Trop. 2011;44:762-770.